Review: taking Vyvanse and Chantix together


Summary

Drug interactions are reported among people who take Vyvanse and Chantix together. This review analyzes the effectiveness and drug interactions between Vyvanse and Chantix. It is created by eHealthMe based on reports of 42 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Vyvanse and Chantix >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 7,909 users)

Chantix

Chantix has active ingredients of varenicline tartrate. It is often used in quit smoking. (latest outcomes from Chantix 63,650 users)

On Jul, 27, 2016

42 people who take Vyvanse, Chantix are studied.


Number of reports submitted per year:

Vyvanse and Chantix drug interactions.

Drug effectiveness over time:

Vyvanse:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 100.0% - (1 of 1 people)
Chantix:
  • < 1 month: 66.0% - (2 of 3 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vyvanse:
  • female: 100.0% - (6 of 6 people)
  • male: 50.0% - (1 of 2 people)
Chantix:
  • female: 75.0% - (3 of 4 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 80.0% - (4 of 5 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Chantix:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • abnormal dreams
  • agitation
  • drug ineffective
  • hallucination
  • malaise
  • tobacco user
  • vitreous floaters
  • weight decreased
  • abnormal behaviour
1 - 6 months:
  • depression
  • excessive hunger
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • irritability
  • mood altered
  • stress
6 - 12 months:
  • aggression
  • anger
  • depression
  • suicidal ideation
2 - 5 years:
  • aggression
  • anger
  • depression
  • suicidal ideation
10+ years:
  • excessive hunger
  • exhaustion, fatigue, lethargy, tiredness, weariness
not specified:
  • drug ineffective
  • fatigue
  • hallucination
  • nausea
  • agitation
  • depression
  • irritability
  • abnormal dreams
  • malaise
  • myalgia

Most common drug interactions by gender *:

female:
  • drug ineffective
  • hallucination
  • abnormal dreams
  • malaise
  • nausea
  • tobacco user
  • vitreous floaters
  • depression
  • fatigue
  • weight decreased
male:
  • abnormal behaviour
  • aggression
  • agitation
  • depression
  • frustration
  • insomnia
  • irritability
  • nausea
  • somnolence
  • stress

Most common drug interactions by age *:

10-19:
  • abnormal behaviour
  • aggression
  • agitation
  • depression
  • frustration
  • insomnia
  • irritability
  • somnolence
  • stress
  • suicidal ideation
20-29:
  • excessive hunger
  • exhaustion, fatigue, lethargy, tiredness, weariness
30-39:
  • abnormal dreams
  • drug ineffective
  • hallucination
  • malaise
  • nausea
  • tobacco user
  • vitreous floaters
  • depression
  • nasopharyngitis
  • respiratory tract congestion
40-49:
  • hallucination
  • abdominal discomfort
  • bipolar i disorder
  • blood cholesterol increased
  • depression
  • disturbance in attention
  • drug ineffective
  • fatigue
  • hot flush
  • irritability
50-59:
  • arterial occlusive disease
  • balance disorder
  • blood pressure increased
  • depression
  • disturbance in attention
  • dizziness
  • fatigue
  • weight decreased
  • aggression
  • anger
60+:
  • agitation
  • anxiety
  • panic attack

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vyvanse and Chantix?

Can you answer these questions?

More questions for: Vyvanse, Chantix

You may be interested in these reviews

More reviews for: Vyvanse, Chantix

On eHealthMe, Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Chantix (varenicline tartrate) is often used to treat quit smoking. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.